Cargando…
Sodium–glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia–reperfusion injury: a meta-analysis
AIMS/HYPOTHESIS: Large cardiovascular outcome trials demonstrated that the cardioprotective effects of sodium–glucose cotransporter 2 (SGLT2) inhibitors might reach beyond glucose-lowering action. In this meta-analysis, we sought to evaluate the potential infarct size-modulating effect of SGLT2 inhi...
Autores principales: | Sayour, Alex Ali, Celeng, Csilla, Oláh, Attila, Ruppert, Mihály, Merkely, Béla, Radovits, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940278/ https://www.ncbi.nlm.nih.gov/pubmed/33483761 http://dx.doi.org/10.1007/s00125-020-05359-2 |
Ejemplares similares
-
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
por: Sayour, Alex Ali, et al.
Publicado: (2020) -
Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021) -
Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
por: Sayour, Alex Ali, et al.
Publicado: (2019) -
Left Ventricular SGLT1 Protein Expression Correlates with the Extent of Myocardial Nitro-Oxidative Stress in Rats with Pressure and Volume Overload-Induced Heart Failure
por: Sayour, Alex Ali, et al.
Publicado: (2021) -
Myocardial work index: a marker of left ventricular contractility in pressure‐ or volume overload‐induced heart failure
por: Lakatos, Bálint Károly, et al.
Publicado: (2021)